Team L&M Adar Poonawalla, Chief Executive Officer, Serum Institute of India (SII), has said that SII has associated with US-based biotechnology firm Codagenix and developed a virus-vaccine candidate which is closest to the novel coronavirus. According to Poonawalla, human trials of the vaccine are expected to commence by September-October. Excerpts from an exclusive interview: What […]Read More
